Merck might be paying peanuts, but at least we are
not paying at all….I don’t get the negativity here by
those who have held and sold…if you are searching
for justification for selling that’s well and good and a
personal choice but the fact of the matter is, is that
immutep aren’t paying a Zac for keytruda in this trial.
to me that’s a positive, keytruda free and Efti remains property of immutep… I may be simple minded but that’s
a win to me..
Ann: Immutep completes institutional pro-rata offer & placement, page-34
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $480.0M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.5¢ | 32.0¢ | $1.703M | 5.215M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 211685 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 279000 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |